These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1121005)

  • 21. Synthesis and potential anticonvulsant activity of new N-3-substituted 5,5-cyclopropanespirohydantoins.
    Zhu Q; Pan Y; Xu Z; Li R; Qiu G; Xu W; Ke X; Wu L; Hu X
    Eur J Med Chem; 2009 Jan; 44(1):296-302. PubMed ID: 18396358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and anticonvulsant activity of new 1-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyrrolidine-2,5-diones.
    Kamiński K; Rzepka S; Obniska J
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5800-3. PubMed ID: 21875804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticonvulsants. 4. Metharbital and phenobarbital derivatives.
    Vida JA; Hooker ML; Samour CM
    J Med Chem; 1973 Dec; 16(12):1378-81. PubMed ID: 4765864
    [No Abstract]   [Full Text] [Related]  

  • 24. 3-Hydroxymethylphenytoin valproic acid ester, a new prodrug combining two anticonvulsant drugs.
    Scriba GK
    Arch Pharm (Weinheim); 1996 Dec; 329(12):554-5. PubMed ID: 9038424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anticonvulsant activities of 4-N-substituted arylsemicarbazones.
    Pandeya SN; Kohli S; Siddique N; Stables JP
    Pol J Pharmacol; 2003; 55(4):565-71. PubMed ID: 14581715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and anticonvulsant activity of N-3-arylamide substituted 5,5-cyclopropanespirohydantoin derivatives.
    He X; Zhong M; Zhang T; Wu W; Wu Z; Yang J; Xiao Y; Pan Y; Qiu G; Hu X
    Eur J Med Chem; 2010 Dec; 45(12):5870-7. PubMed ID: 20947222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-alkylaminocarbazoles as potential anticonvulsant and diuretic agents.
    Shoeb A; Anwer F; Kapil RS; Popli SP
    J Med Chem; 1973 Apr; 16(4):425-7. PubMed ID: 4716190
    [No Abstract]   [Full Text] [Related]  

  • 28. Phenytoin-based bivalent ligands: design, synthesis and anticonvulsant activity.
    Botros S; Khalil NA; Naguib BH; El-Dash Y
    Arch Pharm Res; 2012 Dec; 35(12):2105-16. PubMed ID: 23263804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of three N-(carboxyanilinomethyl) derivatives of p-isopropoxyphenylsuccinimide on the anticonvulsant action of carbamazepine, phenobarbital, phenytoin and valproate in the mouse maximal electroshock-induced seizure model.
    Luszczki JJ; Cioczek JD; Kocharov SL; Andres-Mach M; Kominek M; Zolkowska D
    Eur J Pharmacol; 2010 Dec; 648(1-3):74-9. PubMed ID: 20826140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one and Its Derivatives.
    Zhang HJ; Jin P; Wang SB; Li FN; Guan LP; Quan ZS
    Arch Pharm (Weinheim); 2015 Aug; 348(8):564-74. PubMed ID: 26053879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the anticonvulsant properties of 2-diethylaminopento-4-ynoyl-2',6'-xylidide (WY 21745) with lignocaine, phenytoin, phenobarbitone and trimethadione.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1971 Jun; 191(2):405-14. PubMed ID: 5559826
    [No Abstract]   [Full Text] [Related]  

  • 32. Synthesis and Evaluation of Novel Diazaspiro Hydantoins as Potential Anticonvulsants.
    Kumar CSA; Veeresh B; Ramesha KC; Raj CSA; Mahadevaiah KM; Prasad SBB
    Cent Nerv Syst Agents Med Chem; 2017; 17(3):201-208. PubMed ID: 28707581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functionalized amino acid anticonvulsants: synthesis and pharmacological evaluation of conformationally restricted analogues.
    LeTiran A; Stables JP; Kohn H
    Bioorg Med Chem; 2001 Oct; 9(10):2693-708. PubMed ID: 11557357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Anticonvulsant Activity of Substituted-1,3-diazaspiro[4.5]decan-4-ones.
    Aboul-Enein MN; El-Azzouny AA; Saleh OA; Amin KM; Maklad YA; Hassan RM
    Arch Pharm (Weinheim); 2015 Aug; 348(8):575-88. PubMed ID: 26032619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rational conception, synthesis and evaluation of phenytoinergic potential anticonvulsants. A series ofretrobenzamides: N-(nitrophenyl) benzamides and N-(aminophenyl) benzamides].
    Bourhim M; Kanyonyo MD; Lambert DM; Poupaert JH; Stables JP; Vamecq J
    J Pharm Belg; 1997; 52(5):181-9. PubMed ID: 9432526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new type of anticonvulsant: 1-aryl-3-oxotetrahydroisoquinolines.
    Deák G; Dóda M; György L; Hazai L; Sterk L
    J Med Chem; 1977 Nov; 20(11):1384-8. PubMed ID: 915897
    [No Abstract]   [Full Text] [Related]  

  • 38. An experimental evaluation of anticonvulsant activity of Vitex-negundo.
    Tandon VR; Gupta RK
    Indian J Physiol Pharmacol; 2005 Apr; 49(2):199-205. PubMed ID: 16170989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoalkanolic derivatives of xanthone with potential antiepileptic activity.
    Marona H; Górka Z; Szneler E
    Pharmazie; 1998 Apr; 53(4):219-23. PubMed ID: 9583083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and anticonvulsant activity of novel purine derivatives.
    Wang SB; Jin P; Li FN; Quan ZS
    Eur J Med Chem; 2014 Sep; 84():574-83. PubMed ID: 25062008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.